platinum-containing doublet induction therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for platinum-containing doublet induction therapy, covering 2023-05-17 to 2023-05-17. Get the full timeline:
Most recent: Clinical Trial Update: The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer [Phase 3]